Analysts: Apple Estimates Will Go Up and 2 Other Research Notes To Check Out
Apple (NASDAQ:AAPL): JPMorgan says Apple’s decline in valuation could reverse, as the risk-on trade eases up. A sharp pullback in shares is cited as cause for concerns around revenue deceleration, increasing competition, deterioration of gross margins, and a lack of product catalysts. The firm believes consensus estimates could grow higher during the year, and it keeps and Overweight rating and $725 price target.
CSX Corp. (NYSE:CSX): Stephens thinks that CSX’s multiple will eventually expand, and that the company slighty edged over Q1 operation expectations. Underlying business is strong in non-coal sectors, and that strength will become more apparent in FY2014 said the firm, which raised its price target to $28 from $26, with an Overweight rating.
Akamai (NASDAQ:AKAM): Morgan Stanley only sees limited upside to Akamai’s stock, and expects the company’s Q1 to be in-line, albeit withincrementalrisk to its Q2 guidance and decelerating FY2013 growth. It maintains an Equal Weight rating on the shares.
Don’t Miss: Apples Next Big Thing: iFingerprint?